Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. MCK
stocks logo

MCK

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2026Q2
FY2026Q3
95.66B
+20.65%
8.306
+5.4%
103.79B
+10.83%
8.736
+23.57%
105.22B
+10.41%
9.651
+20.19%
Estimates Revision
The market is revising Upward the revenue expectations for McKesson Corporation (MCK) for FY2026, with the revenue forecasts being adjusted by 2% over the past three months. During the same period, the stock price has changed by 20.81%.
Revenue Estimates for FY2026
Revise Upward
up Image
+2%
In Past 3 Month
EPS Estimates for FY2026
Revise Upward
up Image
+1.29%
In Past 3 Month
Stock Price
Go Up
up Image
+20.81%
In Past 3 Month
12 Analyst Rating
up Image0
Wall Street analysts forecast MCK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MCK is 731.18 USD with a low forecast of 675.00 USD and a high forecast of 805.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Buy
3 Hold
0 Sell
Strong Buy
up Image0
Current: 724.180
sliders
Low
675.00
Averages
731.18
High
805.00
up Image0
Current: 724.180
sliders
Low
675.00
Averages
731.18
High
805.00
B of A Securities
Michael Cherny
Strong Buy
Maintains
$755 → $800
2025-05-09
Reason
B of A Securities
Michael Cherny
Price Target
$755 → $800
2025-05-09
Maintains
Strong Buy
Reason
UBS
Kevin Caliendo
Strong Buy
Maintains
$708 → $805
2025-04-29
Reason
UBS
Kevin Caliendo
Price Target
$708 → $805
2025-04-29
Maintains
Strong Buy
Reason
UBS raised the firm's price target on McKesson to $805 from $708 and keeps a Buy rating on the shares.
B of A Securities
Michael Cherny
Strong Buy
Maintains
$665 → $755
2025-04-11
Reason
B of A Securities
Michael Cherny
Price Target
$665 → $755
2025-04-11
Maintains
Strong Buy
Reason
Mizuho
Steven Valiquette
Hold
Maintains
$630 → $690
2025-04-03
Reason
Mizuho
Steven Valiquette
Price Target
$630 → $690
2025-04-03
Maintains
Hold
Reason
Mizuho analyst Steven Valiquette raised the firm's price target on McKesson to $690 from $630 and keeps a Neutral rating on the shares. McKesson closed its acquisition of Prism Vision on Wednesday, and Mizuho expects the company to close its pending $2.5B majority stake acquisition in Florida Cancer Specialists "soon," the analyst tells investors in a research note. The firm is modeling 45c-50c accretion from 9-10 months of FCS in the new fiscal 2026 EPS estimate of $37.00.
Morgan Stanley
Erin Wright
Buy
Maintains
$642 → $745
2025-04-02
Reason
Morgan Stanley
Erin Wright
Price Target
$642 → $745
2025-04-02
Maintains
Buy
Reason
Morgan Stanley analyst Erin Wright raised the firm's price target on McKesson to $745 from $642 and keeps an Overweight rating on the shares. Drug distributors have re-rated higher and have held relatively steady in volatility, notes the analyst, who believes this should continue given the group's "robust fundamental backdrop." Noting that McKesson typically excludes MCK Venture contributions from long-term guidance, the firm expects FY26 EPS growth can slightly exceed the high end of the company's 12-14% long-term range excluding the impact of MCK Ventures, the analyst tells investors.
Wells Fargo
Stephen Baxter
Hold
Maintains
$641 → $691
2025-03-14
Reason
Wells Fargo
Stephen Baxter
Price Target
$641 → $691
2025-03-14
Maintains
Hold
Reason
Wells Fargo raised the firm's price target on McKesson to $691 from $641 and keeps an Equal Weight rating on the shares. The firm's 2025 adjusted EPS is unchanged, but Wells is increasing forward estimates on modestly stronger Pharma growth and more credit for annualizing Medical cost cuts. The firm cites modestly higher multiple, modestly higher core estimates, and including PRISM for the target change.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Mckesson Corp (MCK.N) is 18.97, compared to its 5-year average forward P/E of 13.47. For a more detailed relative valuation and DCF analysis to assess Mckesson Corp 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Overvalued
5Y Average PE
13.47
Current PE
18.97
Overvalued PE
16.75
Undervalued PE
10.19

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Overvalued
5Y Average EV/EBITDA
10.30
Current EV/EBITDA
13.33
Overvalued EV/EBITDA
12.60
Undervalued EV/EBITDA
8.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Overvalued
5Y Average PS
0.16
Current PS
0.21
Overvalued PS
0.20
Undervalued PS
0.13

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress areBuying! The buying amount has increased100%over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

MCK News & Events

Events Timeline

(ET)
2025-05-13
06:22:08
Trump's drug-price crackdown may lead to minor concessions, WSJ reports
select
link
2025-05-12 (ET)
2025-05-12
10:59:57
White House publishes Trump executive order aimed at lowering drug prices
select
link
2025-05-12
10:28:47
Trump says will 'cut out middlemen' to reduce drug prices
select
Sign Up For More Events
Sign Up For More Events

News

Preview
2.0
05-16NASDAQ.COM
USMV, IBM, MCK, WCN: Large Inflows Detected at ETF

  • USMV Share Price Analysis: USMV's share price is currently at $93.28, within a 52-week range of $81.34 to $95.119, and its performance can be analyzed using the 200-day moving average.

  • ETFs Trading Dynamics: Exchange traded funds (ETFs) operate like stocks but involve trading 'units' that can be created or destroyed based on investor demand, impacting the underlying holdings significantly.

Preview
8.5
05-16NASDAQ.COM
Fund Update: FLPUTNAM INVESTMENT MANAGEMENT CO Just Disclosed New Holdings

  • Portfolio Update: FLPUTNAM INVESTMENT MANAGEMENT CO has filed a portfolio update reflecting its holdings for the period ending March 31, 2025, which can be viewed on Quiver Quantitative.

  • Stock Moves: The report indicates significant stock moves, although estimates may contain inaccuracies due to potential filing or parsing errors.

Preview
5.0
05-16NASDAQ.COM
Fund Update: FLPUTNAM INVESTMENT MANAGEMENT CO added 28,216 shares of MCKESSON ($MCK) to their portfolio

  • FLPUTNAM Investment Management Activity: FLPUTNAM has increased its holdings in McKesson Corp ($MCK) by 28,216 shares according to a recent SEC filing, while 789 institutional investors have added shares and 805 have reduced their positions in the last quarter.

  • Insider and Analyst Trading Insights: Over the past six months, McKesson insiders have sold stock without making any purchases, while members of Congress have made four purchases and two sales; analysts have issued one buy rating with no sell ratings for $MCK.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Mckesson Corp (MCK) stock price today?

The current price of MCK is 724.18 USD — it has increased 2.46 % in the last trading day.

arrow icon

What is Mckesson Corp (MCK)'s business?

McKesson Corporation is a provider of diversified healthcare services. The Company is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada.

arrow icon

What is the price predicton of MCK Stock?

Wall Street analysts forecast MCK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MCK is 731.18 USD with a low forecast of 675.00 USD and a high forecast of 805.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Mckesson Corp (MCK)'s revenue for the last quarter?

Mckesson Corp revenue for the last quarter amounts to 90.82B USD, increased 18.95 % YoY.

arrow icon

What is Mckesson Corp (MCK)'s earnings per share (EPS) for the last quarter?

Mckesson Corp. EPS for the last quarter amounts to 10.00 USD, increased 66.39 % YoY.

arrow icon

What changes have occurred in the market's expectations for Mckesson Corp (MCK)'s fundamentals?

The market is revising Upward the revenue expectations for McKesson Corporation (MCK) for FY2026, with the revenue forecasts being adjusted by 2% over the past three months. During the same period, the stock price has changed by 20.81%.
arrow icon

How many employees does Mckesson Corp (MCK). have?

Mckesson Corp (MCK) has 45000 emplpoyees as of May 17 2025.

arrow icon

What is Mckesson Corp (MCK) market cap?

Today MCK has the market capitalization of 90.60B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free